|
Match
|
Document |
Document Title |
|
|
8163806 |
Controlled release of biologically active compounds from multi-armed oligomers
The present invention relates to the discovery of biodegradable multi-armed oligomers wherein the end groups of these oligomers have been functionalized with biologically active molecules. The...
|
|
|
8066906 |
Polymerizable compound and polymerizable composition
A polymerizable compound represented by general formula (1): wherein A represents a ring assembly composed of at least two 6-membered rings each optionally having a substituent; X1 and X2 each...
|
|
|
8008297 |
Lysine based compounds
The present invention provides lysine based compounds of the formula; and when the compound of formula I comprises an amino group, pharmaceutically acceptable ammonium salts thereof, wherein R1 may...
|
|
|
7538165 |
Conductive polyaniline composition, film thereof and processes for producing these
The invention provides an electrically conductive polyaniline composition comprising polyaniline which contains at least one of novolac resins selected from the group consisting of phenolsulfonic...
|
|
|
7446222 |
Phenyl compounds
Compounds of formula (I) or derivatives thereof: wherein A, B, Z, R1, R2a, R2b, Rx, R8, and R9 are as defined in the specification, a process for the preparation of such compounds, pharmaceutical...
|
|
|
7388008 |
Lysine based compounds
The present invention provides lysine based compounds of the formula; and when the compound of formula I comprises an amino group, pharmaceutically acceptable ammonium salts thereof, wherein R1 may...
|
|
|
7365196 |
Sulphonamido-substituted bridged bicycloalkyl derivatives
A class of compounds is disclosed, comprising sulphonamido-substituted bridged bicycloalkyl structures. The compounds are inhibitors of gamma-secretase, and hence are useful in the treatment of...
|
|
|
7217831 |
Insecticide and method of controlling insects
An insecticide of formula 1 and the agriculturally acceptable salts thereof, wherein: R1 is selected from the group consisting of:the group OR5 wherein R5 is selected from the group consisting of...
|
|
|
7199265 |
Thyroid receptor ligands, pharmaceutical compositions comprising them and their use in the treatment of disorders influenced by thyroid hormones
This invention relates to compounds of the formula (I) which are thyroid receptor ligands, and are preferably selective for the thyroid hormone receptor β, to methods of preparing such compounds ...
|
|
|
6936636 |
5-[phenyl-tetrahydronaphthalene-2-yl dihydronaphthalen-2-yl and heteroaryl-cyclopropyl]-pentadienoic acid derivatives having serum glucose reducing activity
Compounds of the formula: where the variables have the meaning defined in the specification are capable of reducing serum glucose levels in diabetic mammals without the undesirable side effects of...
|
|
|
6906046 |
Pharmaceutical uses and synthesis of benzobicyclooctanes
Benzobicyclooctane compounds, their use in inhibiting cellular events involving TNF-α and IL-8, and in the treatment of inflammation events in general; a combinatorial library of diverse ...
|
|
|
6875895 |
Bis (diphenylvinyl) arene compound
Provided is a bis(diphenylvinyl)arene compound having a reactive functional group on phenyl group, represented by below formula (1), wherein, Ar is an arylene group and has one or more...
|
|
|
6846890 |
Norbornene derivative and norbornene polymer obtained therefrom through ring opening polymerization
A novel norbornene derivative represented by a general formula (1m) shown below is provided. By conducting a ring opening polymerization of this norbornene derivative, or by performing a subsequent...
|
|
|
6747148 |
Sulfonamide derivatives as inhibitors of bone resorption and as inhibitors of cell adhesion
Sulfonamide derivatives, their physiologically tolerable salts and their prodrugs according to the present invention are vitronectin receptor antagonists and inhibitors of cell adhesion, as well as...
|
|
|
6632816 |
Aromatic derivatives as HIV aspartyl protease inhibitors
The present invention provides HIV aspartyl protease inhibitors of the formula; and when the compound of formula I comprises an amino group, pharmaceutically acceptable ammonium salts thereof,...
|
|
|
6603012 |
RAR selective retinoid agonists
New compounds containing bicyclic fused rings, one of which being a phenyl moiety connected by an aliphatic chain to a cycloalkyl or aryl moiety, and pharmaceutically active salts thereof are...
|
|
|
6326510 |
Bi-aromatic compounds, compositions containing them and uses
The invention relates to novel biaromatic compounds having general formula I ##STR1##and their use in pharmaceutical compositions for use in human and veterinary medicine, in particular for...
|
|
|
6291702 |
Azulenyl nitrone spin trapping agents, methods of making and using same
The present invention relates to chromotropic nitrone spin trapping agents, methods of making these agents, compositions comprising same, and methods of their use. In particular, azulenyl nitrones...
|
|
|
6277845 |
Hydrazono-benzazulene derivatives, pharmaceutical compositions and intermediates
Compounds of the formula ##STR1##wherein the substituents are as defined in the application and their pharmaceutically acceptable acid and base salts thereof which are useful for preventing loss of...
|
|
|
6265603 |
Inhibitors of isoprenyl transferase
Peptidomimetic isoprenyl transferase inhibitors R6SCHR1'CHR1WCHR2YC(:X)NR3CHR5COR4 wherein R1=OH, H, alkyl, amino group or R1 and R6 together form a heterocyclic ring; R1'=H, alkyl, aryl; R2=H,...
|
|
|
6258977 |
Alkyl3-oxoalkanoates
An alkyl 3-oxoalkanoate, a process for preparation and use for the synthesis of fatty hydroxylated amino acids, fatty amino alcohols and ceramides.
|
|
|
6201019 |
Bi-aromatic compounds bound by a heteroethynylene radical and pharmaceutical and cosmetic compositions containing same
Bi-aromatic compounds linked via a heteroethynylene radical are provided along with pharmaceutical and cosmetic compositions containing these compounds and methods for their use.
|
|
|
H001950 |
Processes for preparing indeno[1,2-E][1,3,4]oxadiazine-dicarboxylates
Oxadiazines of formula I, wherein R1 is F, Cl or fluoroalkoxy and R2 is alkyl, are prepared by reacting hydrazine derivatives of formula II with a dialkoxymethane in the presence of a protic acid...
|
|
|
6166072 |
Amino acid derivatives
Described herein are compounds having the general formula: ##STR1## wherein: Ar1 and Ar2 are independently selected aryl groups, optionally substituted with substituents selected from the group...
|
|
|
6110955 |
Metabolically stabilized oxyalkylene esters and uses thereof
This invention relates to compositions for and methods of treating, preventing or ameliorating cancer and other proliferative diseases as well as methods of inducing wound healing, treating...
|
|
|
6018068 |
Naphthyloxyacetic acid derivatives and drugs comprising the same as active ingredients
The naphthyloxyacetic acid derivatives of the formula (I) ##STR1## wherein A is H, --(alkylene)COOR1, --(alkylene)CONR2 R, --(alkylene)OH, --(alkylene)tetrazole, --(alkylene)CN; E is single bond or...
|
|
|
5945561 |
Retinoid-like compounds
Certain novel substituted (5,6)-dihydroanthracenyl compounds of the general formula ##STR1## wherein A, n, p, R1, R2, R3, R4, R5, R6, R7 and R8 are as defined in the specification exhibit...
|
|
|
5889053 |
Farnesyl transferase inhibitors, preparation thereof and pharmaceuticals compositions containing said inhibitors
Novel farnesyl transferase inhibitors of general formula (I), ##STR1## the preparation thereof and pharmaceutical compositions containing said inhibitors, are disclosed. In general formula (I), R1...
|
|
|
5866604 |
Thiol derivatives with metallopeptidase inhibitory activity
Compounds of formula (I) wherein R, R1, R2, R3, R4, m and n have the meanings reported in the description, processes for their preparation and pharmaceutical compositions which contain them as...
|
|
|
5849793 |
HIV matrix protein tyrosine position 29 pocket binders
There is disclosed a structural genus of compounds, defined according to coordinates in three-dimensional space, that binds amino moieties on neighboring lysine residues in a tyrosine residue 29...
|
|
|
5843999 |
2-phenylazulene derivatives and a manufacturing method of these compounds
A series of new azulene derivatives are disclosed, which are represented by the following formula; ##STR1## wherein: R1 is hydrogen atom, lower alkoxycarbonyl group, carboxy group, halogen atom,...
|
|
|
5843910 |
Colchicine derivatives and the therapeutical use thereof
The present invention relates to novel colchicine derivatives of formula (1), where Y is a --CH2 --CH--NH--R3 group or a --CH--CH2 OR3 group and the other variables are as defined in claim 1,...
|
|
|
5837807 |
Tetrahydronaphthalene compounds
This invention is directed to tetrahydronaphthalene compounds of the formula ##STR1## wherein R1 is hydrogen, bromine, cyano, formyl, hydroxy, lower alkyl, lower alkenyl, lower alkynyl, lower...
|
|
|
5808124 |
O- or S-substituted dihydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity
Compounds of the formula ##STR1## where the symbols have the meaning described in the application, have retinoid-like or retinoid antagonist-like biological activity.
|
|
|
5760048 |
Alpha-mercaptoacrylic acid derivatives having calpain inhibitory activity
The invention covers a novel series of α-mercaptoacrylic acid derivatives that inhibit both calpain I and calpain II with a high affinity and selectivity. The compounds are useful in the treatment ...
|
|
|
5741819 |
Arylsulfonylaminobenzene derivatives and the use thereof as factor Xa inhibitors
The present invention is directed to non-peptidic factor Xa inhibitors which are useful for the treatment of arterial and venous thrombotic occlusive disorders, inflammation, cancer, and...
|
|
|
5739374 |
Processes of preparing diphenylheteroalkyl derivatives
Diphenylheteroalkyl derivatives of the formula I ##STR1## where A and R1 -R6 have the meanings specified in the description, and the preparation thereof are described.The substances are suitable...
|
|
|
5728864 |
Liquid crystal compound having ferrielectric phase and liquid crystal composition
A liquid crystal compound of the formula (1) ##STR1## wherein R is a linear alkyl group having 6 to 12 carbon atoms, both X and Y are hydrogen atoms or one of X and Y is a fluorine atom and the...
|
|
|
5723493 |
Naphthyloxyacetic acid
(1) Naphthyloxyaetic acid represented by the compound of the formula (I): ##STR1## and non-toxic salts thereof, (2) process for the preparation of the compounds represented by the compound of the...
|
|
|
5705533 |
10-thio-substituted 1,8-dihydroxy-9 (10H) -anthracenone pharmaceuticals
10-thio-substituted 1,8-dihydroxy-9(10H) anthracenones, therapeutic compositions containing at least one of the 10-thio-substituted 1,8-dihydroxy-9(10H) anthracenones of the invention and methods...
|
|
|
5693846 |
Process for preparation of 4-mercapto-1-naphthol compounds
A process for preparation of 4-mercapto-1-naphthol compounds which comprises the steps of: (i) obtaining a 4-heterocyclylthio-1-naphthol compound by reacting a 1-naphthol compound with a...
|
|
|
5676923 |
Substituted DTPA monoamides of the central carboxylic acid group and their metal complexes
Diethylenetriaminepentaacetic acid monoamide derivatives, their complexes and complex salts, containing an element of atomic numbers 21-29, 31, 32, 39, 42-44, 49 or 57-83, pharmaceutical agents...
|
|
|
5618931 |
Acetylenes disubstituted with a 5 substituted dihydronaphthyl group and with an aryl or heteroaryl group having retinoid-like biological activity
Compounds of the formula ##STR1## wherein the symbols have the meaning described in the specification have retinoid-like biological activity.
|
|
|
5574017 |
Antibacterial agents
The present invention provides methods and pharmaceutical preparations for inhibiting the growth of bacterial microorganisms.
|
|
|
5536867 |
Process for the manufacture of dicarboxamides
The present invention is directed to a process, and novel intermediates used in the manufacture of, dicarboxamides of the formula I ##STR1## wherein A, G, L, Q, X and Y have the meaning given in...
|
|
|
5536874 |
Process for preparing arylacetic acid and arylpropionic acid derivatives
There is provided a process for preparing an arylacetic acid or arylpropionic acid divative from an arylcarbinol which comprises the step of subjecting said arylcarbinol to suitable carbonylation...
|
|
|
5536870 |
Process for preparing olefins
A process for preparing olefin compounds of the formula ##STR1## where A is aryl, substituted aryl, heteroaryl, substituted heteroaryl, benzyl, substituted benzyl, vinyl or substituted vinyl and...
|
|
|
5530014 |
Cyclohexadiene derivatives
The cyclohexadiene derivatives are prepared by reaction of cyclohexanones with amines and subsequent dehydration. The compounds are suitable as active compounds in medicaments on account of their...
|
|
|
5523456 |
Inhibitors of farnesyl-protein transferase
The present invention comprises analogs of the CAAX motif of the protein Ras that is modified by farnesylation in vivo. These CAAX analogs inhibit the farnesylation of Ras. Furthermore, these CAAX...
|
|
|
5514683 |
Bicyclo 2,2,2!octane derivatives
The compounds of the formula I ##STR1## and their pharmaceutical acceptable salts, which are defined herein, are ligands for cholecystokinin and/or gastrin receptors.
|